Latest News and Press Releases

BTCS Reports Full Year 2025 Financial Results

Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma Recommendation based on positive results demonstrating...

Arletta Pharma reports >60% clitoral blood flow improvement with Lybrido™ in Phase II study, achieving statistical significance in women with FSIAD.

SAN JOSÉ, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Lexlegis, an AI-first legal technology company, marked a significant global milestone at NVIDIA GTC 2026, unveiling its advanced legal AI...

sNDA submitted seeking approval of IGALMI® in the at-home (outpatient) setting for the treatment of acute agitation associated with bipolar disorders or schizophrenia sNDA submission timeline...

Autolus announces its operational and financial results for the fourth quarter and full year ended December 31, 2025.

- Total revenues from sales and research collaborations were $0.5 million for fourth quarter and $2.0 million for full year -  - Purchase commitment received for a minimum of $1.475 million for a...

Yasam Ayavefe supports nature-linked development in Dubai as marine preservation and sustainable tourism gain a bigger role in long-term growth.

DUBAI, United Arab Emirates, March 27, 2026 (GLOBE NEWSWIRE) -- The new launch enables traders to access leading US stocks beyond standard market hours with greater flexibility and continuity. ...

Pruritus therapeutics market to reach $15.58 Bn by 2035, driven by rising skin disorders, strong biologics pipeline, and expanding global treatment demand.